SAL_10317 | cDNA, FLJ92374, highly similar to Homo sapiens | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.26 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | B2R582 | ProteinSAL_10319 | Cystatin-A | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.72 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | P01040 | ProteinSAL_10321 | Fibrinogen gamma chain | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.44 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | P02679 | ProteinSAL_10323 | HCG40889, isoform CRA_b | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.25 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | A0A024R962 | ProteinSAL_10325 | Hemopexin | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.33 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | P02790 | ProteinSAL_10327 | Immunoglobulin lambda variable 4-60 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.77 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | A0A075B6I1 | ProteinSAL_10329 | Inositol monophosphatase 2 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.78 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | O14732 | ProteinSAL_10331 | Inter-alpha-trypsin inhibitor heavy chain H4 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.24 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | B7ZKJ8 | ProteinSAL_10333 | Interleukin-1 receptor antagonist protein | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.75 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | P18510 | ProteinSAL_10335 | MS-F1 heavy chain variable region | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.76 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | A0A125U0V1 | ProteinSAL_10337 | Neutrophil defensin 1 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.55 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | P59665 | ProteinSAL_10339 | Plasma protease C1 inhibitor | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.23 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | E9PGN7 | ProteinSAL_10341 | Protein AMBP | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.32 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | P02760 | ProteinSAL_10343 | Prothrombin | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.34 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | P00734 | ProteinSAL_10345 | S100 calcium-binding protein A2 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.73 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | P29034 | ProteinSAL_10347 | Serpin family B member 10 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.76 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | Q4VAX6 | ProteinSAL_10349 | Solute carrier family 3 member 2 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 1.38 | Upregulated | NA | Homo sapiens | 30169911 | 2018 | J3KPF3 | ProteinSAL_10351 | Thioredoxin | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.77 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | H9ZYJ2 | ProteinSAL_10353 | Uncharacterized protein | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.69 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | Q6PJG0 | ProteinSAL_10355 | WW domain-binding protein 2 | NA | iTRAQ + ELISA | Unstimulated Saliva | Premalignant Disorder | Oral potentially malignant disorders | NA | 0.83 | Downregulated | NA | Homo sapiens | 30169911 | 2018 | Q969T9 | ProteinSAL_11741 | Alpha-1-antitrypsin | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P01009 | ProteinSAL_11742 | Antileukoproteinase | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P03973 | ProteinSAL_11743 | Apoptosis-associated speck-like protein containing a CARD isoform b | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | Q9ULZ3 | ProteinSAL_11744 | CD44 antigen | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P16070 | ProteinSAL_11745 | Collagen alpha-1(I) chain protein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P02452 | ProteinSAL_11746 | Collagen alpha-1(III) chain protein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P02461 | ProteinSAL_11747 | Collagen alpha-1(V) chain protein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P20908 | ProteinSAL_11748 | Complement factor H | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P08603 | ProteinSAL_11749 | Eosinophil cationic protein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P12724 | ProteinSAL_11750 | Hepatocyte growth factor-like protein precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P26927 | ProteinSAL_11751 | Heterogeneous nuclear ribonucleoproteins C1/C2 isoform b | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P07910 | ProteinSAL_11752 | Integrin beta-2 precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P05107 | ProteinSAL_11753 | Kallikrein-1 preproprotein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P06870 | ProteinSAL_11754 | Keratin, type II cytoskeletal 6B | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P04259 | ProteinSAL_11755 | Kininogen-1 isoform 2 precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P01042 | ProteinSAL_11756 | Leucine-rich alpha-2-glycoprotein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P02750 | ProteinSAL_11757 | Protein AMBP preproprotein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P02760 | ProteinSAL_11758 | Protein S100-A11 | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P31949 | ProteinSAL_11759 | Protein S100-A12 | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P80511 | ProteinSAL_11760 | Protein S100-A7 | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P31151 | ProteinSAL_11761 | Protein S100-A7A | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | Q86SG5 | ProteinSAL_11762 | Protein S100-P | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P25815 | ProteinSAL_11763 | Serpin B4 | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P48594 | ProteinSAL_11764 | Serum amyloid P-component precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P02743 | ProteinSAL_11765 | Thrombospondin-1 precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P07996 | ProteinSAL_11766 | Thymidine phosphorylase isoform 1 proprotein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P19971 | ProteinSAL_11767 | Thyroxine-binding globulin precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P05543 | ProteinSAL_11768 | UV excision repair protein RAD23 homolog B isoform 1 | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P54727 | ProteinSAL_11769 | Vasodilator-stimulated phosphoprotein | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P50552 | ProteinSAL_11770 | Vitronectin precursor | NA | LC-MS/MS + ELISA | Saliva | Premalignant Disorder | Dysplastic leukoplakia (LP) | NA | >1.5 | Upregulated | NA | Homo sapiens | 31706945 | 2019 | P04004 | ProteinSAL_11907 | S100A7 | Diagnostic | ELISA | Whole Saliva | Premalignant Disorder | Oral submucous fibrosis | NA | NA | Upregulated | NA | Homo sapiens | 32334479 | 2020 | P31151 | ProteinSAL_16502 | Arginine | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral epithelial dysplasia | NA | NA | NA | NA | Homo sapiens | 30539290 | 2019 | 6322 | MetaboliteSAL_16505 | Carnitine | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral epithelial dysplasia | NA | NA | NA | NA | Homo sapiens | 30539290 | 2019 | 288 | MetaboliteSAL_16508 | N-Acetylglucosamine-1-phosphate | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral epithelial dysplasia | NA | NA | NA | NA | Homo sapiens | 30539290 | 2019 | 440272 | MetaboliteSAL_16511 | o-Hydroxybenzoate | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral epithelial dysplasia | NA | NA | NA | NA | Homo sapiens | 30539290 | 2019 | 54675850 | MetaboliteSAL_16514 | Ornithine | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral epithelial dysplasia | NA | NA | NA | NA | Homo sapiens | 30539290 | 2019 | 6262 | MetaboliteSAL_16517 | ribose 5-phosphate | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral epithelial dysplasia | NA | NA | NA | NA | Homo sapiens | 30539290 | 2019 | 77982 | MetaboliteSAL_16520 | (S)-Ureidoglycolic acid | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 9.974 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 439269 | MetaboliteSAL_16522 | 1-methylhistidine | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 15.170439 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 92105 | MetaboliteSAL_16524 | 12-amino-octadecanoic acid | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | -10.148185 | Downregulated | NA | Homo sapiens | 30714209 | 2019 | 5312961 | MetaboliteSAL_16526 | 13-cis-retinol | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 11.23105 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 9904001 | MetaboliteSAL_16528 | 16-iodo-hexadecanoic acid | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 16.46654 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 41111 | MetaboliteSAL_16530 | 17beta-Estradiol | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 12.7399435 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 5757 | MetaboliteSAL_16532 | 2-Hydroxymestranol | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 10.119617 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 198049 | MetaboliteSAL_16534 | 2-Oxoarginine | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 17.555275 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 558 | MetaboliteSAL_16536 | 3-Hydroxylidocaine glucuronide | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | -11.584233 | Downregulated | NA | Homo sapiens | 30714209 | 2019 | 101705702 | MetaboliteSAL_16538 | 4-Hydroxyaminoquinoline N-oxide | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 13.103778 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 5360001 | MetaboliteSAL_16540 | 4-Nitroquinoline-1-oxide | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 6.774 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 5955 | MetaboliteSAL_16542 | 6 beta-Hydroxytriamcinolone acetonide | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 18.346615 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | NA | MetaboliteSAL_16544 | 9-chloro-10-hydroxy-hexadecanoic acid | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 8.606354 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 656826 | MetaboliteSAL_16546 | D-Glycerate-2-phosphate | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 0.2286948 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 439278 | MetaboliteSAL_16548 | D-Urobilinogen | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 12.702057 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 440784 | MetaboliteSAL_16550 | Deoxycholic acid disulfate | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 17.007912 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 457190 | MetaboliteSAL_16552 | Deoxypodophyllotoxin | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | -9.543235 | Downregulated | NA | Homo sapiens | 30714209 | 2019 | 345501 | MetaboliteSAL_16554 | Dextrorphan sulfate | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 14.292724 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 92135625 | MetaboliteSAL_16556 | Dihydroisolysergic acid II | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 15.05382 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 129723742 | MetaboliteSAL_16558 | Estradiol valerate | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | -11.359117 | Downregulated | NA | Homo sapiens | 30714209 | 2019 | 13791 | MetaboliteSAL_16560 | Estrone 3-glucuronide | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 1.109 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 115255 | MetaboliteSAL_16562 | Estrone 3-sulfate | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 16.48 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 3001028 | MetaboliteSAL_16564 | Etidronic acid | Diagnostic | Q-TOF-liquid chromatography-mass spectrometry | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 2.515133 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 3305 | MetaboliteSAL_16566 | Etoposide glucuronide | NA | CE-TOFMS | Saliva | Premalignant Disorder | Oral leukoplakia | NA | 0.8115954 | Upregulated | NA | Homo sapiens | 30714209 | 2019 | 46173784 | Metabolite | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |